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The RIFLE criteria, an international defini-
tion for AKI, were used in a retrospective
study of patients undergoing aortic surgery.
Predictors for AKI were hypertension,
CKD, pRBCs greater than 5 units, and a
higher than predicted admission creatinine;
predictors for mortality were age, AKI by
RIFLE, and CVA.
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554 The Journal of Thoracic and Cardbjective: The RIFLE criteria are new international consensus definitions for acute
idney injury introduced to facilitate research across disciplines. We identified risk
actors for acute kidney injury, renal replacement therapy, and mortality using the
IFLE criteria (RIFLE risk, injury, failure, loss, end stage) in patients undergoing
eep hypothermic circulatory arrest for aortic arch reconstruction.
ethods: A single-center retrospective cohort study of 267 patients undergoing
ortic arch surgery with deep hypothermic circulatory arrest was conducted between
uly 2001 and October 2005. Known predictors (age, chronic kidney disease,
urgery status, redo, diabetes, hypertension, blood transfusion, bypass, and deep
ypothermic circulatory arrest time) were used in multivariate logistic regression
odels for acute kidney injury, renal replacement therapy, and mortality.
esults: Mean age was 64 years (range 23–89 years) with 166 men (62%).
eventy-five (28%) had RIFLE scores of I or F, and 22 (8%) required dialysis. Risk
actors for acute kidney injury were hypertension (odds ratio [OR]  2.17; 95%
onfidence intervals [CI], 1.14–4.15), chronic kidney disease (OR  9.04; 95% CI,
.97–41.59), packed red blood cells greater than 5 units (OR  2.37; 95% CI,
.20-4.69), and admission creatinine/Modification of Diet in Renal Disease pre-
icted creatinine ratio greater than 1 (OR  3.54; 95% CI, 1.95–6.45). Risk factors
or mortality were age (per 10 years) (OR 2.35; 95% CI, 1.35–4.06), AKI (RIFLE
lass R, I, or F) (OR  4.60; 95% CI, 1.34–15.77), and cerebrovascular accident
OR  19.1; 95% CI, 4.96–73.58). Mortality increased with each RIFLE stratifi-
ation (RIFLE class 0  3%, R  9%, I  12%, and F  38%).
onclusions: Acute kidney injury as defined according to the RIFLE classification
s a risk factor for mortality and will be useful in future studies of renal dysfunction
n thoracic aortic surgery.
ore than 30 years have elapsed since deep hypothermic circulatory arrest
(DHCA) was introduced for cerebral protection during aortic arch sur-
gery.1 Improved surgical and anesthetic techniques have facilitated -
reasingly complex aortic reconstructions with decreased morbidity and mortal-
ty.2-4 However, postoperative acute kidney injury (AKI) remains a signifi
roblem in the setting of DHCA, with an incidence ranging from 8% to 50%,
lthough various definitions have been used.5-7 Renal dysfunction leads to increas
ostoperative morbidity and mortality, and patients requiring renal replacement
herapy (RRT) have mortality as high as 64%.2,8-13
Several studies have examined AKI after DHCA, with multiple definitions
ncluding the following: 50% increase in serum creatinine above baseline5,14; 25%
eduction in calculated creatinine clearance6; and need for dialysis.15 The variety o
efinitions hinders comparison between studies of kidney injury.14 Accordingly, the
cute Dialysis Quality Initiative Workgroup set forth a new international consensus
efinition for renal injury (RIFLE criteria), which stratifies renal failure into three
rades of increasing severity of acute kidney injury (R  risk, I  injury, F 
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A
CDailure) and two outcome classes (L  loss, and E 
nd-stage kidney disease) (Table 1). The three grade
everity for AKI are based on changes in either serum
reatinine or urine output from baseline.16
The RIFLE criteria previously have been validated in
atients undergoing coronary artery bypass and valve sur-
ery.17 However, in that patient population the incidence
enal dysfunction was low with only 8.5% of patients meet-
ng criteria for I or F classification. The purpose of this
tudy is to validate the RIFLE criteria as a classification
cheme for AKI in a more homogeneous group of patients
ndergoing DHCA for aortic arch surgery, in which there is
higher incidence of renal injury. Multivariate analysis was
erformed to identify risk factors for postoperative kidney
njury and mortality using the new RIFLE criteria.
atients and Methods
fter Institutional Review Board approval, the medical
ecords of patients undergoing thoracic aortic surgery at
hands Hospital at the University of Florida between July
001 and October 2005 were retrospectively reviewed. Dur-
ng this period, 281 patients required DHCA for operations
nvolving the aortic arch, and they comprise the cohort for
he present analysis. Patients who died intraoperatively
ere excluded, inasmuch as no change in renal function
Abbreviations and Acronyms
AKI  acute kidney injury
CI  confidence interval
CKD  chronic kidney disease
CPB  cardiopulmonary bypass
CVA  cerebrovascular accident
DHCA deep hypothermic circulatory arrest
GFR  glomerular filtration rate
MDRDModification of Diet in Renal Disease
OR  odds ratio
PRBCs packed red blood cells
RIFLE risk, injury, failure, loss, end stage kidney
disease
RRT  renal replacement therapy
ABLE 1. Description of the RIFLE system in acute renal f
GFR criteria
isk Plasma creatinine increase 1.5  baselin
njury Plasma creatinine increase 2  baseline
ailure Plasma creatinine increase 3  baseline
or acute plasma creatinine  4 mg/dL
oss Persistent ARF  complete loss of kidne
dialysis for  4 wk but  3 mo
nd stage End-stage kidney disease requiring dialyFR, Glomerular filtration rate; ARF, acute renal failure.
The Journal of Thoracicould be identified. It should be noted that patients with a
istory of advanced chronic kidney disease (CKD stage 4
ith estimated glomerular filtration rate [GFR]  30 ml ·
in1 · 1.73 m2) or CKD stage 5 (long-term RRT) were
lso excluded. The rationale for this exclusion was that it is
lready known that patients with severe kidney disease
efined as CKD stage 4 or 5 are already on or will progress
o RRT and have poor outcomes.18 Patients with CKD
tages 1 to 3 with or without AKI were included in the
nalysis inasmuch as the emphasis was to evaluate these
atients with either preoperative normal renal function or
nly mild-to-moderate impairment. In total, 14 patients
ere excluded; therefore 267 patients were included in the
IFLE analysis.
Demographic and operative variables previously re-
orted to be associated with postoperative renal dysfunction
ere compiled into the cardiac surgery database, which was
anaged by an experienced research nurse.19,20 Demo-
raphic variables included age, gender, previous history of
iabetes mellitus, hypertension (defined as patients with a
ocumented history of hypertension previously being
reated with an antihypertensive agent), cerebrovascular dis-
ase (defined by history of stroke or transient ischemic
ttack or known carotid occlusive disease  50%), periph-
ral vascular disease, and chronic obstructive pulmonary
isease; predicted serum creatinine according to the Modi-
cation of Diet in Renal Disease (MDRD) formula,21 his-
ory of CKD (defined above), primary operation versus
eoperation (“redo”), use of aprotinin (Trasylol; Bayer,
est Haven, Conn) or epsilon aminocaproic acid (Amicar;
anodyne, Florence, Ky), and surgical status (elective ver-
us emergency). Operative variables measured were: car-
iopulmonary bypass (CPB) time, aortic crossclamp time,
HCA time, and need for more than 5 units of packed red
lood cells (pRBCs) intraoperatively and/or first 7 days
ostoperatively. Patients were classified according to the
aximum RIFLE (RIFLEmax) class (risk R, injury I, or
ailure  F) reached during the first 7 days after the oper-
tion. The RIFLE class was determined on the basis of the




GFR decline  25% 0.5 mL · kg1 · h1  6 h
FR decline  50% 0.5 mL · kg1 · h1  12 h
FR decline  75% 0.3 mL · kg1 · h1  24 h
or anuria  12 h
ction requiring















































































































he primary outcomes analyzed were AKI, need for post-
perative RRT, and in-hospital mortality. Need for reopera-
ion during the same hospitalization and postoperative ce-
ebrovascular accident (CVA) as determined by a formal
eurologic evaluation were recorded as well.
perative Procedure
lective ascending and aortic arch operations were per-
ormed through a standard median sternotomy with dual-
tage venous cannulation of the right atrium. Epiaortic scan-
ing was used in ascending aortic aneurysms before aortic
annulation to confirm the absence of mural thrombus or
alcification. Acute ascending aortic dissections were can-
ulated via an axillary or femoral artery. Before cannula-
ion, heparin was administered (350 IU/kg). CPB was ini-
iated only after assuring kaolin-activated clotting times
ere greater than 480 seconds. Almost all patients received
protinin, typically “full dose” (2  106 units intravenous
oad, 2 106 units in the pump prime, and 5 105 units/h);
minority of patients in our early experience received
psilon aminocaproic acid. Cardioplegic arrest was obtained
ith handheld antegrade cardioplegia catheters in the cor-
nary ostia and with retrograde cardioplegia catheters in the
oronary sinus; cardioplegic solution was redosed at 20-
inute intervals via the retrograde catheter. Patients were
onitored with cerebral oximetry and intraoperative elec-
roencephalography. Temperature monitoring included na-
opharyngeal, rectal, and bladder probes. Circulatory arrest
as initiated after confirming no cerebral activity on the
lectroencephalogram with nasopharyngeal temperature at
8°C. Retrograde cerebral perfusion via a snared superior
ena cava cannula was used when circulatory arrest times
ere greater than 20 minutes.
ata Analysis
trained registered nurse database manager reviewed
ecords of demographic, intraoperative, and postoperative
ariables, which were subsequently assembled in our insti-
utional Microsoft Excel database (Microsoft, Redmond,
ash). Data were then exported to Statistica for analysis
StatSoft, Inc, Tulsa, Okla). Demographic and operative
ariables were compared among four groups (RIFLE
lasses 0, R, I, and F) using analysis of variance and the 2
r Fisher exact tests where appropriate for continuous and
ategorical variables, respectively. Risk factors of AKI (de-
ned by RIFLE classes R, I, or F) were determined by
nivariate logistic regression. Known risk factors for renal
ysfunction and univariate predictors with P values .05 in
he present analysis were then entered into a logistic regres-
ion model to identify independent risk factors for AKI.
dds ratios (OR) and 95% confidence intervals (CI) werealculated. The same methods were used to identify vari- t
556 The Journal of Thoracic and Cardiovascular Surgery ● Decbles independently associated with RRT and mortality.
he model for RRT did not include AKI, as by definition all
atients who require RRT are considered to be in RIFLE
lass F. To determine an independent effect with regard to
ortality, we incorporated AKI into the mortality logistic
egression model in addition to other significant variables
Table 2).
esults
he mean age of the 267 patients was 64 years (range
3–89 years). There were 166 men (62%), and 101 women
38%). Comorbidities included diabetes (12%), hyperten-
ion (67%), coronary artery disease (46%), cerebrovascular
isease (9%), chronic obstructive pulmonary disease (14%),
istory of CKD (9%), and peripheral vascular disease (8%).
ifty-seven patients (21%) underwent redo procedures, and
2 (91%) of these operations were performed in an elective
etting. Ninety-five patients in this series required DHCA
or aortic dissection repair; of these dissections, the majority
ere acute aortic dissections as only 24 (25%) were chronic
n nature. Operations were performed on an emergency
asis for 97 patients (36%), and 71 of these were acute
issections. Aprotinin was administered to 239 (88.8%),
nd the remainder received epsilon aminocaproic acid; these
roups differed significantly only in that more patients
ndergoing redo operations received aprotinin. Median
PB time was 175 minutes and median DHCA time was 18
inutes. One hundred seventy-six patients underwent con-
omitant valvular operations and 83 required simultaneous
oronary artery bypass grafting. Demographic and operative
ariables are depicted according to RIFLE severity grades
n Table 3. Significant differences among the four gr
ere detected for the following variables: age, hyperten-
ion, CAD, emergency surgery, mean CPB time, mean
HCA time, pRBCs greater than 5 units, and mean chest
ABLE 2. Multivariate predictors for mortality
ariable OR 95% CI P value
KI (all RIFLE stages) 4.60 1.34–15.77 .01
ge (per 10 years) 2.34 1.35–4.06 .01
istory of CAD 2.45 0.79–7.63 .12
ypertension 0.65 0.22–1.95 .44
edo 0.65 0.18–2.41 .52
mergency surgery 1.57 0.58–4.42 .39
PB time  200 min 1.21 0.36–4.01 .76
HCA time  31 min 1.33 0.46–3.87 .59
RBCs  5 units 1.65 0.51–5.38 .40
VA 19.1 4.95–73.58 .01
eoperation 2.75 0.42–17.86 .29
R, Odds ratio; CI, confidence interval; CAD, coronary artery disease; CPB,
ardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest;
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A
CDDuring the first 7 postoperative days, 129 patients (48%)
ad an episode of AKI: 54 (20%) had RIFLEmax class R, 33
12%) RIFLEmax class I, and 42 (16%) RIFLEmax class F.
he overall incidence of RRT was 8%, and 13 of these 22
atients died. Of the 9 surviving patients with RRT, 5
ecovered and no longer required dialysis, whereas 4 (1.5%
verall) left the hospital on a dialysis regimen. Nineteen
7%) patients had postoperative CVA, and 11 (4%) required
eoperation during the same hospital admission. Overall,
here were 36 (13.4%) deaths within 30 days, which in-
luded 7 intraoperative deaths. Nineteen of the 97 (19%)
atients whose operations were undertaken in an emergency
etting died. However, 161 patients underwent purely elec-
ive operations, and the mortality rate was 8.0% in this
roup. Of these patients, 122 had nonredo operations, with
6.5% mortality rate.
Mortality rates increased with worsening severity of re-
al injury according to RIFLEmax classification: 4 of 138
3%) RIFLEmax class 0, 5 of 54 (9%) RIFLEmax class R, 4
f 33 (12%) RIFLE class I, and 16 of 42 (38%) RIFLEmax
lass F patients died, respectively (Figure 1). Breakdow
atients according to RIFLE severity score and mortality
ata are presented in Table 4.
Logistic regression analysis identified four independent
isk factors for AKI (RIFLE classes R, I, or F): hypertension
OR  2.18, 95% CI 1.14–1.48), pRBCs greater than 5
nits (OR 2.37, 95% CI 1.20–4.69), history of CKD (OR
9.04, 95% CI 1.97–41.59), and ratio of admission creat-
nine/MDRD predicted creatinine greater than 1 (OR 
.54, 95% CI 1.95–6.45). Aprotinin was included in the
ABLE 3. Patient characteristics and operative variables b
RIFLE-0 (n  138) RI
emographics
Age, y 61
Male gender, n (%) 88 (64)
Hypertension, n (%) 80 (58)
Diabetes mellitus, n (%) 17 (12)
COPD, n (%) 16 (12)
CAD, n (%) 52 (38)
PVD, n (%) 10 (7)
Redo status, n (%) 28 (20)
Emergency surgery, n (%) 43 (32)
perative variables
Mean CPB time, min (SD) 174 (48)
Mean DHCA time, min (SD) 22 (15)
Mean crossclamp time, min (SD) 106 (53)
pRBCs  5 units, n 30 (22)
Mean chest tube output, mL 1149
OPD, Chronic obstructive pulmonary disease; CAD, coronary artery di
tandard deviation; DHCA, deep hypothermic cardiopulmonary bypass; pR
isease. †Analysis of variance performed to test for differences among gtatistical model and was not found to be a significant
The Journal of Thoracicredictor for renal dysfunction; however, in this series only
minority of patients (11%) had not received aprotinin
Table 5).
Three variables were independently associated with RRT
n logistic regression analysis: history of CKD (OR 4.86,
5% CI 1.40–16.86), pRBCs greater than 5 units (OR 
1.5, 95% CI 2.73–48.41), ratio of admission creatinine/
DRD predicted creatinine greater than 1 (OR  8.58,
5% CI, 1.01–72.88). Redo surgical status (OR  0.12,
5% CI 0.02–0.72) was found less likely to be associated
ith postoperative RRT (see Table 6).
For mortality, age (per 10 years), history of CAD, hy-
ertension, redo, emergency surgery, AKI (RIFLE classes
, I, or F), CPB time, DHCA time, pRBCs greater than 5
nits, postoperative CVA, and need for reoperation were
ntered into the logistic regression model. Significant pre-
ictors for in-hospital mortality were AKI (OR 4.60, 95%
FLE classification8
(n  54) RIFLE-I (n  33) RIFLE-F (n  42) P value†
5 67 66 .02
0 (55) 22 (67) 26 (62) .69
6 (85) 25 (76) 29 (69) .002
5 (9) 6 (18) 4 (9) .61
7 (13) 6 (18) 9 (21) .38
8 (52) 19 (58) 23 (55) .05
6 (11) 2 (6) 4 (9) .78
5 (28) 7 (21) 7 (17) .58
4 (26) 15 (46) 25 (60) .01
0 (49) 215 (82) 203 (76) .01
4 (16) 26 (17) 28 (15) .05
5 (45) 124 (64) 111 (55) .11
6 (29) 16 (48) 31 (74) .01
0 1424 1914 .01
; PVD, peripheral vascular disease; CPB, cardiopulmonary bypass; SD,















BCs,Figure 1. Final disposition according to RIFLE classification.
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A
CDI 1.34–15.77), age per 10 years (OR  2.35, 95% CI
.35–4.07), and postoperative CVA (OR  19.10, 95% CI
.96 –73.58) (see Table 2).
iscussion
enal complications after aortic surgery are common; how-
ver, the multitude of definitions used has complicated
omparison between series.22 The purpose of this report w
o validate the new international consensus RIFLE classifi-
ation scheme for AKI in the setting of aortic arch surgery.
he RIFLE criteria were established in 2004 by the Acute
ialysis Quality Initiative, incorporating both laboratory
nd clinical parameters to assess renal function. A recent
eport used the RIFLE system in a contemporary cardiac
urgery population17; however, in that series the majority
atients were at low risk for renal complications. The
resent study examines patients undergoing aortic arch sur-





(% of RIFLE category)
Thirty-day
mortality No.
(% of RIFLE category)
IFLE-0 138 (52%) 0 (0%) 4 (3%)
isk 54 (20%) 0 (0%) 5 (9%)
njury 33 (12%) 0 (0%) 4 (12%)
ailure 42 (16%) 22 (63.6%) 16 (38%)
otal 267 22 36
RT, Renal replacement therapy. *RIFLE  risk, injury, failure, loss, and
nd-stage kidney disease. †Data were available to compute RIFLE scores
or 267 patients. There were 7 intraoperative deaths, 2 CKD without AKI,
nd 5 chronic hemodialysis patients who were excluded from RIFLE
nalysis. ‡According to original RIFLE description, all patients with post-
perative RRT classified as RIFLE-F.
ABLE 5. Multivariate Analysis for AKI (All RIFLE stages)
ariable OR 95% CI P value
Age (per 10 y) 1.22 0.96–1.55 .09
History of CAD (yes vs no) 1.21 0.64–2.28 .55
Hypertension (yes vs no) 2.18 1.14–4.14 .02
Redo 1.15 0.53–2.50 .72





Emergency surgery 0.93 0.49–1.77 .84
CPB time 200 min 1.14 0.56–2.30 .71
DHCA time 31 min 1.38 0.70–2.72 .35
pRBCs 5 units 2.37 1.20–4.69 .01
KI, Acute kidney injury; OR, odds ratio; CI, confidence interval; CAD,
oronary artery disease; CKD, chronic kidney disease; MDRD, Modification
f Diet in Renal Disease; CPB, cardiopulmonary bypass; DHCA, deeplypothermic circulatory arrest; pRBCs, packed red blood cells.
558 The Journal of Thoracic and Cardiovascular Surgery ● Decery at high risk for renal injury and found the incidence of
KI as defined by any RIFLE category (R, I, or F) to be
8%, which was over twofold greater than the earlier series.
his finding is not unexpected, inasmuch as both aortic
urgery and DHCA are known to be independent risk fac-
ors for renal dysfunction.20,23
The logistic regression model identified hypertension,
hronic kidney disease, pRBCs greater than 5 units, and
atio admission creatinine/MDRD predicted creatinine
reater than 1 as independent risk factors for renal injury, all
f which are in accordance with earlier reports.6,19 Predic-
ors for RRT also included CKD, pRBCs greater than 5
nits, and ratio admission creatinine/MDRD predicted cre-
tinine greater than 1. Assuming a GFR between 75 and 100
L/min, the MDRD formula can be used to predict a
ormal baseline creatinine. Patients whose admission creat-
nine was greater than MDRD predicted creatinine were at
ncreased risk for AKI and RRT, suggesting that even subtle
bnormalities in creatinine values may portend adverse out-
omes with respect to renal function. Total pRBCs greater
han 5 units was found by Mora Mangano and associate6 to
e independently associated with renal dysfunction. In their
iscussion, they concluded, however, that there was no
irect causality between blood transfusion and renal dys-
unction; rather this finding was a reflection of hypovole-
ia, thought to be the cause for renal dysfunction.6 Simi-
arly, we concur that increased total pRBCs, while used as
lifesaving measure, can be a surrogate marker for the very
ritically ill nature of the patients requiring such volume of
lood products. However, there is evidence from a nonran-
omized trial that increased RBC transfusion may worsen
orbidity and mortality rates in a population of patients
ndergoing isolated coronary artery bypass grafting. Postu-
ABLE 6. Multivariate analysis for RRT
ariable OR 95% CI P value
ge (per 10 y) 0.97 0.61–1.54 .90
istory of CAD 0.89 0.24–3.24 .86
ypertension 1.56 0.45–5.38 .48
edo 0.12 0.02–0.72 .02
istory of CKD 4.86 1.40–16.86 .01
atio of admission
creatinine/MDRD
predicted creatinine  1
8.58 1.01–72.88 .05
mergency surgery 1.28 0.43–3.86 .65
PB time  200 min 1.20 0.34–4.21 .77
HCA time  31 min 2.00 0.62–6.39 .24
RBCs  5 units 11.50 2.73–48.41 .01
RT, Renal replacement therapy; OR, odds ratio; CI, confidence interval;
AD, coronary artery disease; CKD, chronic kidney disease; MDRD, Mod-
fication of Diet in Renal Disease; CPB, cardiopulmonary bypass; DHCA,


















































































Arnaoutakis et al Surgery for Acquired Cardiovascular Disease
A
CDion include proinflammatory end-organ damage and an
dverse immunomodulatory effect on T-cell function.24
Interestingly, the present series found redo surgical status
ssociated with a decreased need for postoperative RRT,
hich is not consistent with other large series.19 We pro-
ose the following explanation for this inconsistency. Pa-
ients in this series predominantly required the use of
HCA for one of two disease processes: (1) acute aortic
issection and (2) aneurysmal aortic disease. Patients who
ad redo operations were more likely to undergo elective
neurysm repair. In comparison, patients with acute aortic
issection less frequently had redo operations and more
requently were operated on in an emergency setting, occa-
ionally in profound shock.
We found that 22 (8%) patients required postoperative
RT (either hemodialysis or continuous venovenous hemo-
ltration), similar to other large series of patients undergo-
ng aortic arch reconstructions.25-27 Among patients requir-
ng RRT postoperatively, 13 (59%) died. This figure
nderscores the bleak prognostic implications of RRT after
ardiovascular surgery, and postoperative RRT has previ-
usly been found to independently predict mortality.11 Oth-
rs have reported similar mortality rates in patients requir-
ng RRT postoperatively, ranging from 28% in a routine
oronary bypass population28 to 57% in patients undergoin
HCA for aortic arch aneurysm repair.27
AKI, advanced age, and postoperative CVA all represent
n independent association with mortality in this series.
dvanced age is a widely known risk factor for periopera-
ive mortality. RRT is a documented risk factor for mortal-
ty, and in this series 8% of the patients required RRT. To
void confounding, we included AKI but not RRT in the
ogistic regression model for mortality. Given the findings
n this study, we conclude that even less severe renal dys-
unction as defined by AKI (RIFLE classes R, I, or F) is
ndependently associated with mortality. Considering that
8% of this cohort met criteria for AKI using the RIFLE
efinition, this suggests that a large number of patients in
he setting of DHCA are at jeopardy for adverse outcomes
ncluding mortality. Increasing mortality was noted with
rogressive RIFLE class as patients with no detectable renal
ysfunction (RIFLE class 0) experienced a mortality of 3%;
owever, this increased proportionately in RIFLE classes R
9%), I (12%), and F (38%), respectively. Others have
ocumented increased mortality with increasing RIFLE
lassification in noncardiac surgery patients29 and in mor
outine cardiac surgery populations.17 We have shown 
imilar result in a more homogeneous population of pa-
ients, who all underwent DHCA for aortic arch repair.
The safety of aprotinin in cardiac surgery remains con-
roversial.30,31 Aprotinin was incorporated into the logis
egression model as a variable, but no association was
dentified. Because a majority of patients in this series
The Journal of Thoraciceceived aprotinin and only a small number did not receive
t, we had low power to detect any significant effect of
protinin in regard to renal dysfunction or mortality.
The RIFLE classification system also includes a differ-
ntiation between RIFLE outcome categories L (loss, tem-
orary dialysis) and E (end-stage permanent dialysis),
hich were not included because this information was not
vailable in our retrospective database. This is a limitation
f the study, because it is not readily known whether these
wo outcomes represent a different long-term risk for mor-
ality. In addition, it is unclear whether increasing severity
f RIFLE score corresponds to a lower likelihood of recov-
ry of renal function. Some patients whose elevation in
reatinine qualifies them for AKI according to the RIFLE
efinition have a return to baseline on hospital discharge,
hereas in others creatine levels remain slightly elevated. It
s unclear whether those who only partially recover from
heir episode of AKI have worse long-term outcomes than
o patients with complete recovery, a question that merits
urther study. The urine output criteria, which also can be
sed to calculate the RIFLE class (see Table 1), 
nother difficulty with using the RIFLE system during ret-
ospective analysis inasmuch as these data are not readily
vailable. Future prospective studies that use the RIFLE
ystem will be able to identify patients who meet the urine
utput criteria for improved RIFLE classification, as well as
o identify patients with temporary (L loss) or permanent (E
nd stage) requirements for RRT.
In summary, we found the RIFLE criteria to be a useful
lassification system for renal failure in patients undergoing
HCA for aortic arch surgery. Future clinical trials de-
igned to study renal protective interventions in aortic sur-
ery should incorporate the RIFLE criteria.
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iscussion
r R. Scott Mitchell (Stanford, Calif ). Dr Arnaoutakis, you and
our colleagues are to be complimented for an excellent report.
Your study embracing the relatively new RIFLE classification
ntroduces a very desirable standardization with three grades of
enal injury—risk, injury, and failure—in increasing severity.
hese grades of severity are based exclusively on postoperative
hanges in plasma creatinine, GFR, or urinary output. Its strengths
re the ability to compare apples with apples, which we desper-
tely need as we manipulate postoperative variables. This is a
uch needed standardization.
Its weakness, to my eye, however, is that it really is predictive
f only things after the surgical event, which is the one time where
e may most capably modulate the renal injury. Certainly intra-
perative variables may be very important to postoperative patient
erformance. I wonder whether you might have included in your
ariables such things as perfusion strategies, antegrade versus
etrograde perfusion through axillary arteries or femoral cannula-
ion, or whether you looked at the effect of temperatures, since
emperature and bypass times may be correlated.
Would you agree that more intraoperative variables might be
ntroduced into this model so that you can be more predictive?
econd, do you think the actual protective effect that you saw for
he reoperative patients was due, as you suggested, to the de-
reased incidence of emergency operations in that patient cohort or
o some other effect?
Dr Arnaoutakis. Thank you, Dr. Mitchell, for your excellent
oints and questions. I should echo the points that you made that
his system is not instated to be a predictive tool, but rather a
lassification system, such that in future studies we would be
omparing apples with apples. The hope is to disseminate a wide-
pread nomenclature that we can use when discussing renal failure.
With respect to your questions regarding variables, in our early
xperience most patients were cannulated by the femoral artery;
owever, recently we have adopted selective use of axillary can-
ulation and we do have plans to review these data and perhaps
ncorporate them into some of our models.
With respect to your second question concerning the redo, this
as a curious finding to us as well. Patients in this series were
omogeneous in that all required use of circulatory arrest; how-
ver, they were operated on primarily for one of two diseases:
ortic aneurysms or acute aortic dissections. In looking back at the
ata, because of this peculiar finding, we found that nearly 90% of

















Arnaoutakis et al Surgery for Acquired Cardiovascular Diseaseisease and most of the acute aortic dissections were first-time
perations and occasionally undertaken in the setting of profound
ystemic shock.
Dr Gary H. Dworkin (Clearwater, Fla). With regard to Dr
itchell’s suggestion of intraoperative variables, did you appreci-
te any changes or look at the use of aprotinin or other antifibrino-
ytics and relate them to your postoperative outcomes?
Dr Arnaoutakis. Thank you, Dr Dworkin, for your questionThe Journal of Thoracicng aprotinin. As a matter of fact, we did look at aprotinin. In
ur early experience, some patients did receive epsilon amin-
caproic acid; however, in this series, the majority of patients,
early 90%, had received aprotinin. We did look at it in the
odel and it did not come out to be significant for any of the
utcomes we looked at. However, we concluded that since there
as such a disparity in the number of patients who received
protinin versus epsilon aminocaproic acid, we had low powerA
CDs well. We are eminently aware of the ongoing debate regard- to detect any significant differences.and Cardiovascular Surgery ● Volume 134, Number 6 1561
